Clinical trial
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver…
NCT00004239 · Alliance for Clinical Trials in Oncology, Other · Terminated
Key facts
| NCT number | NCT00004239 |
|---|---|
| Title | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment |
| Official title | A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Compound 506U78 |
| Enrollment | 10 |
| Start date | Dec 1, 1999 |
| Primary completion | Jan 1, 2002 |
| Completion | Jan 1, 2002 |
| First posted | Jan 29, 2004 |
| Last update posted | Jul 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: